Literature DB >> 12714637

Differential and cooperative effects of TNFalpha, IL-1beta, and IFNgamma on human conjunctival epithelial cell receptor expression and chemokine release.

James L Stahl1, Ellen B Cook, Frank M Graziano, Neal P Barney.   

Abstract

PURPOSE: To gain better understanding of conjunctival epithelial cell responses to proinflammatory cytokines, the individual and combined effects of TNFalpha, IL-1beta, and IFNgamma on chemokine release (IL-8, regulated on activation normal T-cell expressed and secreted [RANTES]) and surface receptor expression (intercellular adhesion molecule [ICAM]-1, and HLA-DR, -DP, and -DQ) were examined.
METHODS: Conjunctival epithelial cells were isolated from cadaveric conjunctival tissues and cultured in 24-well plates until almost confluent. Recombinant cytokines (0.005-50 ng/mL) were added, alone or in various combinations, 24 hours before harvesting of supernates for ELISAs and cells for flow cytometry.
RESULTS: TNFalpha, IL-1beta, and IFNgamma had distinctive individual and combined effects on the parameters tested. Although TNFalpha and IL-1beta had similar and synergistic effects on increasing expression of ICAM-1, IL-1beta was a more potent upregulator of the release of IL-8 than was TNFalpha. Upregulation of IL-8 was additive when IL-1beta was combined with TNFalpha. Neither TNFalpha nor IL-1beta increased expression of HLA. In contrast, IFNgamma was a potent upregulator of both surface receptors (ICAM-1 and HLA) but IFNgamma alone had no effect on mediator release (IL-8 and RANTES). Release of RANTES required two cytokine signals, with IFNgamma and TNFalpha being the most potent combination.
CONCLUSIONS: Knowledge of the differential and combined effects of proinflammatory cytokines on conjunctival epithelial cells allows better understanding of ocular inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714637     DOI: 10.1167/iovs.02-0721

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

2.  Comparative study of topical anti-allergic eye drops on human conjunctiva-derived cells: responses to histamine and IFN gamma and toxicological profiles.

Authors:  Aude Pauly; Françoise Brignole-Baudouin; Jean-Marc Guenoun; Luisa Riancho; Patrice Rat; Jean-Michel Warnet; Christophe Baudouin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-10       Impact factor: 3.117

3.  Molecular Signature of Neuroinflammation Induced in Cytokine-Stimulated Human Cortical Spheroids.

Authors:  Kim M A De Kleijn; Kirsten R Straasheijm; Wieteke A Zuure; Gerard J M Martens
Journal:  Biomedicines       Date:  2022-04-29

4.  Inflammatory Cytokine-Mediated Regulation of Thrombospondin-1 and CD36 in Conjunctival Cells.

Authors:  Laura Soriano-Romaní; Laura Contreras-Ruiz; Laura García-Posadas; Antonio López-García; Sharmila Masli; Yolanda Diebold
Journal:  J Ocul Pharmacol Ther       Date:  2015-07-08       Impact factor: 2.671

5.  Th1- and Th2-type cytokines in chronic ocular allergy.

Authors:  Andrea Leonardi; Iva A Fregona; Mario Plebani; Antonio G Secchi; Virginia L Calder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

6.  Population genetic evidence for positive and purifying selection acting at the human IFN-γ locus in Africa.

Authors:  Michael C Campbell; Lunden T Smith; Jayla Harvey
Journal:  Genes Immun       Date:  2018-03-29       Impact factor: 2.676

7.  Effect of electrocauterization on the inflammation of the conjunctiva in experimental animal model.

Authors:  Kyeong Hwan Kim; Ah Young Ko; Jin Suk Ryu; Mee Kum Kim; Won Ryang Wee
Journal:  Korean J Ophthalmol       Date:  2013-07-04

8.  Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease.

Authors:  James B Koprich; Casper Reske-Nielsen; Prabhakar Mithal; Ole Isacson
Journal:  J Neuroinflammation       Date:  2008-02-27       Impact factor: 8.322

9.  Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells.

Authors:  Megan E Cavet; Stepan Volhejn; Karen L Harrington; Jin-Zhong Zhang
Journal:  Mol Vis       Date:  2013-07-19       Impact factor: 2.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.